Cost-utility analysis of provision of e-cigarette starter kits for smoking cessation in emergency departments: An economic evaluation of a randomized controlled trial.
Brief intervention
Markov model
cost‐effectiveness
economic evaluation
emergency department
e‐cigarette
life‐time modelling
randomized controlled trial
smoking cessation
Journal
Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118
Informations de publication
Date de publication:
31 Oct 2024
31 Oct 2024
Historique:
received:
17
04
2024
accepted:
24
09
2024
medline:
1
11
2024
pubmed:
1
11
2024
entrez:
1
11
2024
Statut:
aheadofprint
Résumé
To assess the cost-effectiveness of the Cessation of Smoking Trial in Emergency Department (COSTED) intervention compared with signposting to local stop smoking service (SSS) from the National Health Service (NHS) and personal social services (PSS) perspective. This was a two-group, multi-centre, pragmatic, individually randomized controlled trial set in six Emergency Departments (EDs) in urban and rural areas in the United Kingdom. Adult (≥ 18 years) daily smokers (at least one cigarette or equivalent per day) but not daily e-cigarette users, with carbon monoxide reading ≥ 8 parts per million, attending the ED (n = 972) were included. The intervention consisted of provision of an e-cigarette starter kit plus brief smoking cessation advice and referral to a local SSS. Control was an information card on how to access local SSS. Intervention costs included costs of training and delivery. Control costs included costs of printing information cards. Costs of smoking cessation and health-care services were estimated based on quantities reported by participants and unit costs extracted from secondary sources. The effects were measured by quality-adjusted life years (QALYs) derived from EQ-5D-5L. Other outcomes were smoking cessation measures. The primary outcome was incremental cost-effectiveness ratio (ICER), which was calculated by dividing the difference in costs by the difference in QALYs between groups. The mean intervention costs were £48 [standard error (SE) = £0] per participant and the mean control costs were £0.2 (SE = £0) per participant. Using regression estimates, total costs were £31 [95% confidence interval (CI) = -£341 to £283] higher and 6-month QALYs were 0.004 (95% CI = -0.004 to 0.014) higher in the intervention group than in the control group. The ICER was calculated at £7750 (probability of cost-effective at range £20 000-30 000: 72.2-76.5%). The UK Cessation of Smoking Trial in Emergency Department (COSTED) intervention (provision of an e-cigarette starter kit plus brief smoking cessation advice) was cost-effective compared with signposting to local stop smoking services under the current recommendations of the maximum acceptable thresholds.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIHR Health Technology Assessment Programme
ID : NIHR129438
Informations de copyright
© 2024 The Author(s). Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.
Références
Department of Health and Social Care (DHSS). Advancing our health: prevention in the 2020s—consultation document London, UK: DHS; 2019.
Office for National Statistics (ONS). Adult smoking habits in the UK. 2022. Available at: ons.gov.uk [accessed 14 Sept 2023]
Khan J. The Khan Review: making smoking obsolete London, UK: DHS; 2022.
Department of Health and Social Care (DHS). Stopping the start: our new plan to create a smokefree generation London, UK: DHS; 2023.
NHS Digital. Hospital Accident and Emergency Activity, 2022–23. Hospital Accident and Emergency Activity. 2023. Available at: nhsdigital.nhs.uk. [accessed 8 July 2024]
Tolmie AD, Erker R, Oyedokun T, Sullivan E, Graham T, Stempien J. Prevalence of cigarette smoking among adult emergency department patients in Canada. West J Emerg Med. 2020;21:190–197.
Bernstein SL, Dziura J, Weiss J, Brooks AH, Miller T, Vickerman KA, et al. Successful optimization of tobacco dependence treatment in the emergency department: a randomized controlled trial using the multiphase optimization strategy. Ann Emerg Med. 2023;81:209–221.
Notley C, Clark L, Belderson P, Ward E, Clark AB, Parrott S, et al. Cessation of smoking trial in the emergency department (CoSTED): protocol for a multicentre randomised controlled trial. BMJ Open. 2023;13:e064585.
Pope I, Clark LV, Clark A, Ward E, Belderson P, Stirling S, et al. Cessation of smoking trial in the emergency department (COSTED): a multicentre randomised controlled trial. Emerg Med J. 2024;41:276–282.
Jones K.C., Weatherly H., Birch S., Castelli A., Chalkley M., Dargan A. et al. Unit Costs of Health and Social Care 2022. https://doi.org/10.22024/UniKent/01.02.100519
National Institute for Health and Care Excellence (NICE). NICE health technology evaluations: the manual (PMG36). In: Process and Methods London, UK: NICE; 2022. p. 196.
NHS Business Services Authority. Prescription cost Analysis—England 2021/22. Prescription Cost Analysis—England. 2022. Available at: nhsdigital.nhs.uk. [accessed 9 Jan 2023]
National Institute for Health and Care Excellence (NICE). British National Formula. London, UK: BMJ Group and Pharmaceutical Press; 2023.
Glassdoor I. Stop smoking advisor salaries in United Kingdom. 2022 Available at: glassdoor.co.uk. [accessed 15 Feb 2023]
National Institute for Health and Care Excellence (NICE). Resource impact report: Tobacco: preventing uptake, promoting quitting, and treating dependence (NG209) London, UK: NICE; 2021.
Curtis LA, Burns A. Unit costs of Health and Social Care 2020 Canterbury, UK: Personal Social Services Research Unit; 2020.
Wu Q, Parrott S, Godfrey C, Gilbert H, Nazareth I, Leurent B, et al. Cost‐effectiveness of computer‐tailored smoking cessation advice in primary care: a randomized trial (ESCAPE). Nicotine Tobacco Res. 2014;16:270–278.
Curtis L, Burns A. Unit costs of Health and Social Care 2016. Canterbury, UK: Personal Social Services Research Unit; 2016.
NHS England, NHS Improvement. National Cost Collection 2021/22. National Cost Collection for the NHS. Available at: nhsdigital.nhs.uk; 2023. [accessed 11 April 2023]
Curtis L, Burns A. Unit costs of health and social care 2015. Canterbury, UK: Personal Social Services Research Unit; 2015.
NHS Business Services Authority. PD1 reports. London, UK: NHS Business Services Authority; 2023.
The EuroQol Group. EQ‐5D‐5L User Guide: Basic information on how to use the EQ‐5D‐5L instrument (version 2.1). Rotterdam, the Netherlands: The EuroQol Group; 2015.
Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ. 2004;13:1203–1210.
van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ‐5D‐5L: mapping the EQ‐5D‐5L to EQ‐5D‐3L value sets. Value Health. 2012;15:708–715.
National Institute for Health and Care Excellence (NICE). Position statement on use of the EQ‐5D‐5L value set for England (updated October 2019) London, UK: NICE; 2019.
Hernandez AM, Pudney S, Wailoo A. Estimating the relationship between EQ‐5D‐5L and EQ‐5D‐3L: results from a UK population study. Pharmacoeconomics. 2023;41:199–207.
West R. Assessing smoking cessation performance in NHS stop smoking Services: the Russell Standard (clinical) London, UK: Cancer Research UK and University College; 2005.
Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost‐effectiveness analysis conducted within randomised controlled trials. Pharmacoeconomics. 2014;32:1157–1170.
Rubin DB. Statistical matching using file concatenation with adjusted weights and multiple imputations. J Bus Eco Stat. 1986;4:87–94.
White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–399.
Briggs AH, Wonderling DE, Mooney CZ. Pulling cost‐effectiveness analysis up by its bootstraps: a non‐parametric approach to confidence interval estimation. Health Econ. 1997;6:327–340.
Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;328:1519–7455.
Drummond M. Methods for the economic evaluation of health care programmes Oxford, UK: Oxford University Press; 2015.
Wu Q, Gilbody S, Li J, Wang HI, Parrott S. Long‐term cost‐effectiveness of smoking cessation interventions in people with mental disorders: a dynamic decision analytical model. Value Health. 2021;24:1263–1272.
Office for National Statistics (ONS). Deaths Registered in England and Wales London, UK: ONS; 2021.
Hughes JR, Peters EN, Naud S. Relapse to smoking after 1 year of abstinence: a meta‐analysis. Addict Behav. 2008;33:1516–1520.
Godfrey C., Ali S., Parrott S., Pickett K. Economic model of adult smoking related costs and consequences for England. Public Health Research Consortium. Available at: http://phrc.lshtm.ac.uk/papers/PHRC_A4-06_Final_Report.pdf 2011. [accessed 18 Feb 2015]
World Health Organization (WHO). Economics of tobacco toolkit: assessment of the economic costs of smoking. Geneva, Switzerland: WHO; 2011.
Royal College of Physicians of London, Tobacco Advisory G, Royal College of Physicians of London, Tobacco Advisory G, Royal College of Physicians of London. Hiding in plain sight: treating tobacco dependency in the NHS: a report. London, UK: Royal College of Physicians; 2018.
Hospital Episode Statistics Analysis, Health and Social Care Information Centre. Hospital Episode Statistics: Accident and Emergency Attendances in England 2014–15 Leeds, UK, 2016: Health and Social Care Information Centre.
Department of Health (DoH). Reference costs 2015–16 London, UK: DoH; 2016.
Vogl M, Wenig CM, Leidl R, Pokhrel S. Smoking and health‐related quality of life in English general population: implications for economic evaluations. BMC Public Health. 2012;12:203.
Population Health, Clinical Audit and Specialist Care, NHS England. Statistics on NHS stop smoking services ‐ England, April 2022 to December 2022 Statistics on NHS Stop Smoking Services—England; 2023 Available at: nhsdigital.nhs.uk. [accessed 23 June 2023]
Miller TR, Johnson MB, Dziura JD, Weiss J, Carpenter KM, Grau LE, et al. Cost‐effectiveness of smoking cessation approaches in emergency departments. Am J Prev Med. 2023;65:39–44.
US Bureau of Labor Statistics. CPI Inflation Calculator Washington, DC: US Bureau of Labor Statistics; 2023.
International Monetary Fund (IMF). Exchange rates selected indicators. International Financial Statistics. Washington, DC: IMF; 2023.
Jackson SE, Shahab L, Kock L, West R, Brown J. Expenditure on smoking and alternative nicotine delivery products: a population survey in England. Addiction. 2019;14:2026–2036.